a. Neurological problems
Neurological problems associated with CMN used to be called Neurocutaneous melanosis. This term is no longer used for two important reasons. The first reason is that some of the problems are not actually “melanosis”, in other words they are not a problem of pigment cells. The second reason is that in the medical literature neurocutaneous melanosis is often actually melanoma of the brain or spinal cord, and this has caused big problems with trying to advise families on diagnosis. We now prefer to call the neurological problems by their actual names – so if it is benign intraparenchymal melanosis (e.g. moles in the brain) we say so, and if it is melanoma of the brain or spine we say so. This allows us to give better information to parents and patients, and has allowed us to divide the causes into serious and less serious. Overall, problems in the brain or spinal cord are the most common complication seen in children with CMN. The most common problem is pigment-containing cells (like a CMN) in the substance of the brain. This is called intraparenchymal melanosis. Other rarer problems include benign brain or spinal tumours, too much fluid in the brain, or abnormal brain structure. All of these neurological problems are more common with larger and more numerous CMN. Our current recommendations are that any child born with two or more CMN should have a routine MRI scan of the brain and spine, preferably by the age of 6 months.The overall chance of finding an abnormality on an MRI scan in children with multiple CMN (two or more at birth) is around 20%, but only around half of these children will have any actual problems. If they do have problems these can be fits (convulsions), developmental delay, or problems with their limbs. It is possible to have problems in development even when the scan is normal, but these tend to be milder.
The most common problem with neuro development is a delay in speech. For children with more than one CMN it is very common to have a delay in speech in the first few years of life. This usually presents itself as a problem with expressive speech- the child’s ability to express what they’re saying whenever they usually understand everything.
This usually catches up with time, as a rule of thumb it could easily be delayed six months but then would catch up. If this problem persisted over time for longer than six months, we would encourage a parent to seek medical advice.
– Why should children with CMN have an MRI? A brain MRI is recommended for every child with born with multiple CMN (more than one at the time of birth, any size or site) to determine the presence of any internal pigment in the brain or nervous system. An earlier MRI allows for a clearer scan, ideally under 6 months of age. The MRI looks for the rare cases of congenital benign tumours and extra fluid on the brain that require an operation, and for the commoner “moles in the brain” which need monitoring of child development more carefully. Some findings alert doctors to monitor children more carefully for the development of melanoma, by having more MRIs. Most children however will only have one scan.
Not only do we recommend this single screening scan, but anyone with multiple CMN (more than one at birth) who develops new problems over their lifetime with development or fits, or persistent headaches over a long period, or any problems which could be due to brain or spine disease, should have a repeat MRI to look for the development of melanoma.
b. Risk of melanoma
Histology (the study of cells under a microscope) of CMN is difficult and often requires specialist review. A review should be carried out by at least two experts in the field. A genetic analysis of an individual’s CMN can help to differentiate melanoma from benign nodules in the skin, or from stable congenital disease in the Central Nervous System.
Small single CMN are common birthmarks with very low risk of melanoma, and do not require routine resection for this reason. Multiple CMN have a higher risk of melanoma due to larger area of skin covered. Different people with different types of CMN have different risks of melanoma; however, the overall absolute risk for all types of CMN taken together is low. Where melanoma does arise in children with multiple CMN, a primary melanoma in the Central Nervous System is more common than in the skin. The strongest statistical risk factor for all‐site melanoma in childhood is an abnormal screening MRI of the Central Nervous System (CNS) in the first 6 months of life. When melanoma does develop in CMN it is highly aggressive. Central Nervous System melanoma currently has 100% mortality, however recent treatments with a drug called Trametinib helps to reduce symptoms and can possibly extend life. We continue to fund pioneering research to find the cure for CMN through our partnership with Professor Kinsler and her research team. We have a vision of a world where no one suffers from CMN.
c. What if I find a new lump or bump in my CMN?
CMN can develop nodules that can cause uncertainty. Histology (the study of cells under a microscope) is difficult and often requires specialist review. Review should be carried out by at least two experts in the field. A genetic analysis of an individual’s CMN can help to differentiate melanoma from benign nodules in the skin, or from stable congenital disease.


